cAse PresenttIon
A 65-year-old Caucasian man with history of hypertension presented with abdominal pain and a skin rash with swelling involving both lower extremities for one week. Prior to admission, he visited an urgent care clinic and received an intramuscular injection of methylprednisolone. He developed nausea and vomiting with increased abdominal pain and was admitted in our hospital. He also complained of diffuse arthralgia but denied fever, chills, diarrhea, recent travel, and contact with ill persons. He denied any prior history of skin rashes or lesions. Vital signs included temperature 98°F, blood pressure 130/82 mmHg, pulse rate 92 beats/minute, respiratory rate 20 breaths/minute, and oxygen saturation 95% on room air. Physical examination was significant for diffuse abdominal tenderness and petechial skin lesions involving the legs and feet. (Figure-1) The initial laboratory studies revealed white blood cell count 17x 10 3 /µL (polymorph 91%, lymphocytes 6%), hemoglobin 14 gm/dL, platelets 41x10 3 /µL, erythrocyte sedimentation rate 8 mm/hr. Liver function tests and serum electrolytes were normal except for creatinine of 1.6 mg/dL. Urine studies showed protein 100 mg/dL and 10 red blood cells per high power field. Repeat urine protein studies showed proteinuria at 2014 mg per 24 hrs. A computed tomography scan of the abdomen reported nonspecific thickening of the large intestine and consistent with early ischemic colitis. Empiric antibiotic therapy was begun and an infectious disease work up was done for HIV, hepatitis B and C, and bacterial infections. By hospital day three, the petechial rash extended up to the abdomen, buttocks, and hands, and anasarca was evident. During the next five days, the patient became anuric and a transaminitis developed with increased aspartate aminotransferase levels (106 IU/L) and alanine aminotransferase levels (91 IU/L). His serum creatinine increased to 5.1 mg/dl, and the BUN increased to 116 mg/dl. All infectious disease work ups were reported to be negative so antibiotics were stopped on hospital day eight. Serologic studies for vasculitis of various etiologies (ANCAs, ANA, cryoglobulins, etc.) were negative. Based on the skin lesions, the abdominal pain and renal failure, the clinical diagnosis of HSP was made. Subsequently, skin and renal biopsies were performed and leukocytoclastic vasculitis and IgA nephropathy with chronic inflammatory changes was reported, respectively (Figure 2a, 2b,  2c) . Methylprednisolone 500mg intravenous twice a day was administered on hospital days 5-8, and the patient was then switched to oral prednisone 90 mg per day. Hemodialysis was started on hospital day eight for acute renal failure and anuria. The patient slowly improved with resolution of the arthralgia, anasarca, abdominal pain and skin lesions. Dialysis was discontinued after three weeks, but oral prednisone was continued and weaned off after three months. At six weeks follow up visit as an outpatient, the patient remained symptom free with return of renal function to base line.
dIscussIon
HSP is typically a disease of children and is very uncommon in adults. 4, 5 The incidence in adults varies from approximately 3 to 14 cases per million, depending upon the particular study and patient ethnicity. 6 It is an immune-mediated systemic leukocytoclastic vasculitis characterized by vascular and/or mesangial IgA deposition.
The etiology of HSP remains unknown; it may be triggered by a variety of antigenic stimuli including infections, drugs, toxins, systemic diseases and cancer. 7, 8 In the present case infectious gastroenteritis was possibly a triggering factor. Episodes of macroscopic hematuria are frequently associated with acute renal failure and HSP-associated IgA nephropathy leads to severe renal failure (CrCl <30 ml/min) in 13% and end stage renal disease in up to 11% of adult patients on long term follow-up. 1 Proteinuria, hypertension, and initial kidney impairment portend an unfavorable renal prognosis with the degree of pro- teinuria being the most significant prognostic factor.
9,10
The definitive diagnosis requires a biopsy of the skin and/or kidney. Pathognomonic features include leukocytoclastic vasculitis and IgA deposits in the dermal capillaries and IgA deposits in the mesangium.
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The use of glucocorticoids is thought to be beneficial for resolving the arthralgias and abdominal pain of HSP. High dose methylprednisolone may be beneficial in patients with advanced renal disease (crescentic nephritis). 12 Alternative therapies include azathioprine, high-dose IV immunoglobulin, mycophenolate mofetil, cyclophosphamide, and thalidomide. 13, 14 There may be a role for plasmaphoresis in the management of HSP. 15 However, there have been no randomized clinical trials to document the efficacy of any of these therapeutic regimens.
In summary, adult onset HSP is a rare disease, often missed at initial presentation. An aggressive diagnostic approach should be employed promptly in such patients to make a timely diagnosis to achieve good clinical outcome. Early initiation of high dose steroids may prevent permanent kidney damage in patients like the present case. 
